ST
IBB icon

Spot Trading’s iShares Biotechnology ETF IBB Stock Holding History

Spot Trading’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$20.7M Buy
186,000
+60,000
+48% +$6.41M 0.36% 21
2017
Q2 		$13M Sell
126,000
-36,600
-23% -$3.6M 0.26% 46
2017
Q1 		$15.9M Buy
162,600
+71,100
+78% +$6.81M 0.53% 17
2016
Q4 		$8.09M Buy
91,500
+89,700
+4,983% +$8.16M 0.19% 105
2016
Q3 		$174K Sell
1,800
-12,600
-88% -$1.2M ﹤0.01% 2163
2016
Q2 		$1.24M Sell
14,400
-73,200
-84% -$6.57M 0.02% 985
2016
Q1 		$7.62M Buy
87,600
+13,800
+19% +$1.23M 0.13% 179
2015
Q4 		$8.32M Sell
73,800
-59,700
-45% -$6.48M 0.09% 301
2015
Q3 		$13.5M Buy
133,500
+129,300
+3,079% +$15.5M 0.13% 157
2015
Q2 		$517K Sell
4,200
-29,400
-88% -$3.52M ﹤0.01% 2099
2015
Q1 		$3.85M Sell
33,600
-43,500
-56% -$4.8M 0.04% 700
2014
Q4 		$7.8M Sell
77,100
-9,900
-11% -$962K 0.05% 558
2014
Q3 		$7.93M Sell
87,000
-22,200
-20% -$1.95M 0.04% 649
2014
Q2 		$9.36M Buy
109,200
+77,100
+240% +$6.07M 0.04% 575
2014
Q1 		$2.53M Sell
32,100
-87,600
-73% -$7.3M 0.01% 1317
2013
Q4 		$9.06M Buy
119,700
+59,400
+99% +$4.21M 0.05% 496
2013
Q3 		$4.21M Buy
+60,300
New +$3.95M 0.03% 846

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Spot Trading's IBB Position: Q3 2017 in Review

Spot Trading reduced its iShares Biotechnology ETF (IBB) stake by 73% in Q3 2017, selling an estimated $3.02M and leaving 10,518 shares worth $1.17M. The position accounts for 0.02% of the portfolio, ranked #1052.

Spot Trading first reported a position in IBB in Q3 2013 and has held it in 12 quarters since. The position peaked at $9.5M in Q3 2015. 583 funds tracked by Wall St. Rank hold IBB as of Q3 2017.

  • Spot Trading held 10,518 shares of iShares Biotechnology ETF worth $1.17M as of Q3 2017.
  • Spot Trading sold 28,239 iShares Biotechnology ETF shares in Q3 2017, an estimated $3.02M.
  • iShares Biotechnology ETF made up 0.02% of Spot Trading's portfolio in Q3 2017, its #1052 holding.
  • Spot Trading first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 12 quarters since.
  • Spot Trading's iShares Biotechnology ETF position peaked at $9.5M in Q3 2015.
  • 583 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.